Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study

NCT05817149 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-04-18

No results posted yet for this study

Summary

We want to test if an association between sentinel lymph node biopsy (SLBN) and a systemic inflammatory response can be made.

Conditions

Interventions

PROCEDURE

Blood samples

Blood samples

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER
  • Aalborg University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-22
Primary Completion
2021-10-06
Completion
2022-01-20

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05817149 on ClinicalTrials.gov